Navigation Links
Aggressive Therapy May Stem CF Progression in Infants
Date:12/5/2008

Treating cystic fibrosis in first 6 months appears most effective, Australian study finds

FRIDAY, Dec. 5 (HealthDay News) -- It may be possible to control the progression of cystic fibrosis through early detection and aggressive treatment of the disease in infants, according to Australian researchers.

They found that progressive lung damage in CF patients can start as early as infancy, even though lung function shortly after diagnosis is normal. The finding challenges current scientific belief.

The study included 68 infants with CF, ages 6 weeks to 30 months, who were compared to a control group of 49 infants without the disease. At 6 months of age, infants with CF had significantly poorer lung function than those in the control group, and that difference increased with each month of age. This shows that lung function in infants with CF declines sooner than previously thought, the researchers said.

They also found that diminished lung function occurred even when there were no clinical symptoms and irrespective of CF genotype.

The most significant finding was that infants with CF had normal lung function test results shortly after birth and within their first six months of life, the researchers said.

"We might be able to stop some of the lung function reduction we're identifying in the first months of life," study author Dr. Sarath Ranganathan, a consultant respiratory physician at the Royal Children's Hospital in Melbourne, said in an American Thoracic Society news release. "We don't know what's going to work, but we have to target those patients in the first six months of life if we're going to be effective."

The study, published in the second issue for December of the American Journal of Respiratory and Critical Care Medicine, validates the early-screening approach used in Australia and indicates that other nations should adopt similar programs, the researchers said.

"Ninety percent of those with CF can't absorb the fat in their diet, and people with this condition who are better nourished live longer," Ranganathan said. CF patients who can't absorb fat "should take manufactured pancreatic enzymes with every meal that contains fat, so they can have a good high-fat diet with lots of calories."

However, Ranganathan noted, "we can't be certain whether or not fat malabsorption that occurs prior to starting enzymes at diagnosis contributes to diminished lung function later on in early childhood."

More information

The March of Dimes has more about cystic fibrosis.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, Dec. 5, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. MedPro Imaging Continues Aggressive U.S. Expansion
2. Women with mitral valve prolapse are treated less aggressively than men and may be at high risk
3. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
4. Less Exposure to Violent Media Makes Youths Less Aggressive
5. Professional Sports Teams Should Use MRSA Screening and Other Aggressive Methods to Prevent Staph Infections
6. American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicares Health
7. Move over mean girls -- boys can be socially aggressive, too
8. Cord Blood America CEO Announces Aggressive Acquisition Strategy, Increased Investor Relations Efforts, New Stem Cell Storage Models
9. PSA screening may be biased against obese men, leading to more aggressive cancers
10. Aggressive preschoolers found to have fewer friends than others
11. Cord Blood America CEO Matthew Schissler Details Aggressive Expansion Strategies in U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aggressive Therapy May Stem CF Progression in Infants
(Date:3/23/2017)... ... March 23, 2017 , ... ... today named The Resource Group as their 2016 Microsoft Dynamics Partner of the ... Newport Beach, CA. The award recognizes The Resource Group for their outstanding ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... seniors, today announced rapid completion of the strategic executive team expansion needed to ... additions to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive ...
(Date:3/23/2017)... ... March 23, 2017 , ... According to the ... poor sleep is likely not the only cause of the sunken-eye look, which can ... you look older or in poor health are likely due to genetics, dehydration, allergies, ...
(Date:3/23/2017)... Kennett Square, PA (PRWEB) , ... March 23, 2017 , ... ... sunny days. That means many students are thinking about summer internships , which ... (or lack thereof). , The pros at Garden Media Group, a boutique public relations ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - Medicure ... leading Canadian specialty pharmaceutical company, is pleased to ... received final approval from the U.S. Food and ... drug application ("ANDA") for tetrabenazine tablets in the ... approved product is a generic equivalent of the ...
(Date:3/23/2017)... The global dermatology devices market  is expected ... according to a new report by Grand View Research, Inc. ... due to rising concern amongst people regarding esthetics. This has ... used for treating hair - and skin-related disorders. Primarily, women ... highest revenue generators for the market. ...
(Date:3/22/2017)... RADNOR, Pennsylvania , 22 de marzo de ... proveedor independiente global líder de soluciones de productos ... ha anunciado hoy que ha adquirido EPL Archives, ... apoya a los clientes en todo el ciclo ... y comercialización ofreciendo una muestra de archivo, almacenamiento ...
Breaking Medicine Technology: